Type Three Diabetes: Are You at Risk?
A Systematic Review
Background

Type three diabetes is a term recently coined to unveil the link
between type 2 diabetes mellitus (T2DM) and dementia, specifically
Alzheimer’s Disease (AD). In 2015,1 type 2 diabetes was the sixth
leading cause of disability in the United States. It is characterized by
unusually high levels of glucose in the blood.2 The etiology of T2DM is
largely due to insulin resistance combined with disturbance in the key
role of insulin producing beta cells.2-5 Alzheimer’s disease is the most
common form of dementia and becomes worse over time.6,7 Brain
glucose metabolism is reduced in AD and glucose metabolism is also
impaired in cells as an epidemiological characteristic of T2DM.8 There
is a growing interest to study the link between these two diseases.
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A systematic review was conducted by searching electronic databases of current literature, published from
January 2010 to January 2019, using the PRISMA Protocol. Articles that met the criteria (subjects >18 years old)
were selected by one reviewer. Electronic databases (PubMed, Cochrane, Proquest, Scopus, PsycInfo, and
SocInfo) were used to find articles with key search words: “Dementia + Type 2 Diabetes Mellitus” OR
“Alzheimer’s Disease + Type 2 Diabetes Mellitus.” Nine studies were used in this systematic review.

Objectives

The object of this systematic review is to investigate the following
research question: How are patients with type 2 diabetes mellitus at
an increased risk for dementia, such as Alzheimer’s Disease, compared
to patients without diabetes? This review examined the link between
these two disease.

This systematic review explains the relationship between type 2
diabetes mellitus and the formation of Alzheimer’s disease. This
review also indicates how those with type 2 diabetes mellitus are at
an increased risk of Alzheimer’s disease because of the metabolic
problems of insufficient insulin for cells; this prevents the uptake of
glucose in cells, as seen in the neurons of the brain. Further study
into oxidative stress will be necessary to clarify the etiology of type
2 diabetes mellitus along with Alzheimer’s disease.
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Results

In this systematic review, the results show a positive association between type 2 diabetes mellitus in mid-life
and later dementia, such as Alzheimer’s Disease.8-13 At the cellular level insulin unlocks the cells’ ability to
metabolize glucose. In type two diabetes mellitus, insulin is resisted by the cell which leaves glucose roaming
the blood with no where to go.1-5 Likewise, the metabolism of glucose in the human brain is completely
dependent on insulin.14 In the event where no insulin is present, glucose, which is an energy source for the
neurons, can not be used and the neurons begin to degenerate. 6,7,10, This degeneration leads to cell death of
the neuron; as a result, cognitive and memory functions are impaired and lead to Alzheimer’s Disease.8-16
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